Moderna Narrows Loss, Reiterates 10% Revenue Growth Target
ModernaModerna(US:MRNA) WSJ·2026-02-13 12:56

Core Viewpoint - Moderna continues to target a 10% revenue growth for the year, indicating a positive outlook despite recent financial performance [1] Financial Performance - The company's fourth-quarter loss has narrowed compared to the same period last year, suggesting improvements in financial health [1]